|
FAR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38839999497264E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.39440000055136E-07 |
| Normal-vs-Stage2 |
9.798100E-03 |
| Normal-vs-Stage3 |
4.205800E-04 |
| Normal-vs-Stage4 |
1.261650E-02 |
| Stage1-vs-Stage2 |
6.153000E-01 |
| Stage1-vs-Stage3 |
6.032000E-01 |
| Stage1-vs-Stage4 |
1.822620E-01 |
| Stage2-vs-Stage3 |
4.482200E-01 |
| Stage2-vs-Stage4 |
3.465800E-01 |
| Stage3-vs-Stage4 |
1.403780E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26889999996216E-06 |
| Normal-vs-AfricanAmerican |
3.465700E-02 |
| Normal-vs-Asian |
9.324800E-03 |
| Caucasian-vs-AfricanAmerican |
8.294400E-01 |
| Caucasian-vs-Asian |
6.302800E-01 |
| AfricanAmerican-vs-Asian |
5.976000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.009500E-04 |
| Normal-vs-Female |
9.9877999981679E-08 |
| Male-vs-Female |
3.659800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.79179999995716E-06 |
| Normal-vs-Age(41-60Yrs) |
1.88822999999116E-05 |
| Normal-vs-Age(61-80Yrs) |
1.881730E-03 |
| Normal-vs-Age(81-100Yrs) |
3.402600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.164200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.414200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.488200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.993800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.583600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.142000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.883600E-01 |
| Classical-VS-Follicular |
1.676640E-01 |
| Classical-VS-Other |
6.839200E-01 |
| Classical-VS-Normal |
2.51240000004316E-06 |
| Tall-VS-Follicular |
9.659200E-01 |
| Tall-VS-Other |
3.607000E-01 |
| Tall-VS-Normal |
2.916400E-03 |
| Follicular-VS-Other |
4.214600E-01 |
| Follicular-VS-Normal |
5.74139999999224E-05 |
| Other-VS-Normal |
4.804400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78429999997398E-07 |
| Normal-vs-N1 |
9.549600E-02 |
| N0-vs-N1 |
7.358500E-03 |
|
|
